Table 2.
Baseline | Post-treatment | ||||
---|---|---|---|---|---|
Measure | Treatment | Pre | Post | Pre | Post |
Bond-Lader Alert | Placebo | 66.96 (16.25) | 58.90 (18.03) | 67.00 (15.26) | 62.50 (18.06) |
Berocca Performance | 66.77 (12.86) | 60.27 (15.46) | 66.43 (15.71) | 58.61 (16.56) | |
Berocca Boost | 66.26 (15.09) | 58.94 (15.89) | 63.98 (13.35) | 60.76 (15.90) | |
Bond-Lader Content | Placebo | 70.67 (11.87) | 64.93 (15.76) | 71.94 (10.98) | 68.70 (12.57) |
Berocca Performance | 72.51 (9.23) | 69.15 (11.69) | 72.14 (10.77) | 67.28 (13.29) | |
Berocca Boost | 72.54 (12.29) | 66.54 (11.50) | 69.46 (11.91) | 69.22 (12.32) | |
Bond-Lader Calm | Placebo | 66.85 (14.24) | 65.50 (13.61) | 62.05 (14.23) | 65.50 (13.61) |
Berocca Performance | 66.35 (14.40) | 64.70 (12.94) | 64.80 (15.60) | 63.45 (14.00) | |
Berocca Boost | 65.95 (15.71) | 62.43 (10.10) | 62.48 (13.81) | 61.85 (13.26) | |
VAS Stress | Placebo | 28.05 (19.85) | 32.70 (19.84) | 28.05 (19.85) | 32.70 (19.84) |
Berocca Performance | 23.70 (15.38) | 32.35 (18.51) | 25.45 (16.47) | 30.90 (17.07) | |
Berocca Boost | 27.20 (23.54) | 38.45 (21.25) | 28.15 (19.20) | 33.50 (19.91) | |
VAS Fatigue | Placebo | 31.80 (18.95) | 37.35 (22.81) | 31.80 (18.95) | 32.70 (19.84) |
Berocca Performance | 31.85 (16.85) | 42.00 (20.12) | 33.15 (16.62) | 43.40 (20.88) | |
Berocca Boost | 37.15 (22.79) | 45.00 (21.03) | 36.15 (15.15) | 39.25 (20.93) |